Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
Aggrecanase (ADAMTS5) |
Target Info
|
Inhibitor |
[1] |
| Aggrecanase-1 (ADAMTS4) |
Target Info
|
Inhibitor |
[1] |
| Matrix metalloproteinase-1 (MMP-1) |
Target Info
|
Inhibitor |
[2] |
| Matrix metalloproteinase-2 (MMP-2) |
Target Info
|
Inhibitor |
[2] |
| Matrix metalloproteinase-3 (MMP-3) |
Target Info
|
Inhibitor |
[3] |
| Matrix metalloproteinase-7 (MMP-7) |
Target Info
|
Inhibitor |
[2] |
| Matrix metalloproteinase-8 (MMP-8) |
Target Info
|
Inhibitor |
[1] |
| Matrix metalloproteinase-9 (MMP-9) |
Target Info
|
Inhibitor |
[1] |
| References |
Top |
| REF 1 |
Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivati... J Med Chem. 2001 Oct 11;44(21):3347-50.
|
| REF 2 |
A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers. J Med Chem. 2003 Jul 31;46(16):3514-25.
|
| REF 3 |
Amide surrogates of matrix metalloproteinase inhibitors: Urea and sulfonamide mimics, Bioorg. Med. Chem. Lett. 7(18):2331-2336 (1997).
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
